Skip to main content
Year archive

Mendus — 2020 filings

All 64 regulatory filings released by Mendus (IMMU) in 2020, sourced directly from the official regulator.

64 Filings
2020 Period
2020 filings (64)
Filing Released Lang
Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment for Hepatocellular Carcinoma (HCC)
Regulatory Filings
2020-12-31 English
Immunicum AB (publ) erhåller särläkemedelsstatus, ODD, från FDA för ilixadencel för behandling av levercancer
Regulatory Filings
2020-12-31 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-12-30 English
Change in Number of Shares and Votes in Immunicum AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2020-12-30 English
Förändring av antal aktier och röster i Immunicum AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2020-12-30 Swedish
Changes to the Nomination Committee for Immunicum AB (publ)
Board/Management Information
2020-12-29 English
Ändringar i valberedningen för Immunicum AB (publ)
Board/Management Information
2020-12-29 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-12-22 English
Kallelse till extra bolagsstämma i Immunicum AB (publ)
AGM Information
2020-12-21 Swedish
Notice of Extraordinary General Meeting in Immunicum AB (publ)
AGM Information
2020-12-21 English
Immunicum AB (publ) Completes Business Combination with DCprime
M&A Activity
2020-12-21 English
Immunicum AB (publ) slutför sammanslagningen med DCprime
M&A Activity
2020-12-21 Swedish
Immunicum AB (publ) offentliggör prospekt avseende upptagande till handel av nyemitterade aktier på Nasdaq Stockholm
Capital/Financing Update
2020-12-18 Swedish
Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasdaq Stockholm
Share Issue/Capital Change
2020-12-18 English
Report from the Extraordinary General Meeting of Immunicum AB (publ) on December 18, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-12-18 English
Kommuniké från extra bolagsstämma i Immunicum AB (publ) den 18 december 2020
Declaration of Voting Results & Voting Rights Announcements
2020-12-18 Swedish
Immunicum AB (publ) publicerar finansiell kalender 2021
Report Publication Announcement
2020-12-16 Swedish
Immunicum AB (publ) Publishes Financial Calendar 2021
Report Publication Announcement
2020-12-16 English
Immunicum AB (publ) Receives FDA Fast Track Designation for Ilixadencel in Gastrointestinal Stromal Tumors (GIST)
Regulatory Filings
2020-12-07 English
Immunicum AB (publ) erhåller Fast Track Designation från FDA för ilixadencel för behandling av GIST
Legal Proceedings Report
2020-12-07 Swedish
Notice of Extraordinary General Meeting in Immunicum AB (publ)
AGM Information
2020-11-18 Swedish
Notice of Extraordinary General Meeting in Immunicum AB (publ)
AGM Information
2020-11-18 English
Immunicum AB and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies
M&A Activity
2020-11-18 English
Immunicum och DCprime går samman för att skapa ett ledande bolag inom cellbaserade immunterapier
M&A Activity
2020-11-18 Swedish
Appointment to the Nomination Committee for Immunicum AB (publ)
Board/Management Information
2020-11-10 English
Komplettering av valberedning i Immunicum AB (publ)
AGM Information
2020-11-10 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-05 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-05 English
Nomination Committee Appointed for the Annual General Meeting 2021 in Immunicum AB (publ)
Board/Management Information
2020-11-04 English
Valberedning utsedd inför årsstämman 2021 i Immunicum AB (publ)
AGM Information
2020-11-04 Swedish
Magnus Persson lämnar styrelsen i Immunicum AB (publ)
Board/Management Information
2020-10-29 Swedish
Magnus Persson to Resign from Immunicum’s Board of Directors
Board/Management Information
2020-10-29 English
Immunicum AB Announces Update on Corporate and Clinical Development Strategy
Investor Presentation
2020-09-30 English
Immunicum AB meddelar uppdatering av bolagets övergripande och kliniska utvecklingsstrategi
Regulatory Filings
2020-09-30 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-27 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-27 English
Immunicum AB (publ) Announces Update on Survival Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer
Legal Proceedings Report
2020-08-18 English
Immunicum AB (publ) meddelar uppdaterade data från fas II-studien MERECA med ilixadencel i njurcancer
Investor Presentation
2020-08-18 Swedish
Immunicum AB (publ) erhåller Regenerative Medicine Advanced Therapy Designation från FDA för Ilixadencel i njurcancer
Regulatory Filings
2020-05-06 Swedish
Immunicum AB (publ) Receives Regenerative Medicine Advanced Therapy Designation from FDA for Ilixadencel in Kidney Cancer
Regulatory Filings
2020-05-06 English
Report from the Annual General Meeting of Immunicum AB (publ) on April 28, 2020
AGM Information
2020-04-28 English
Kommuniké från årsstämma i Immunicum AB (publ) den 28 april 2020
AGM Information
2020-04-28 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-28 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-28 English
Annual Report 2019
Annual Report FY 2019
2020-04-03 Swedish
Annual Report 2019
Annual Report FY 2019
2020-04-03 English
Kallelse till årsstämma i Immunicum AB (publ)
AGM Information
2020-03-27 Swedish
Notice of Annual General Meeting in Immunicum AB (publ)
AGM Information
2020-03-27 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-03-25 English
Immunicum AB (publ) meddelar att bolagets finanschef, Michaela Gertz, lämnar sin tjänst till sommaren 2020
Board/Management Information
2020-03-02 Swedish
Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer
Board/Management Information
2020-03-02 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-28 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-27 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-25 English
Earnings Release 2019
Earnings Release FY 2019
2020-02-18 Swedish
Audit Report / Information 2019
Audit Report / Information FY 2019
2020-02-18 English
Immunicum AB (publ) meddelar uppdaterade data från MERECA-studien med ilixadencel i njurcancer vid ASCO-SITC Clinical Immuno-Oncology-symposiet
Regulatory Filings
2020-02-06 Swedish
Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium
Earnings Release FY 2020
2020-02-06 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-04 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-03 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-27 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-08 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-03 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-01-03 English